Sector: Technology | Industry: Software |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 529 E. Crown Point Rd., Suite 250 OCOEE FL 34761 |
Tel: | N/A |
Website: | https://www.icoreconnect.com |
IR: | See website |
Key People | ||
Robert P. Mcdermott President, Chief Executive Officer, Director | Archit Shah Chief Financial Officer | Jeffrey W. Stellinga Chief Operating Officer, Director |
Muralidar Chakravarthi Chief Technology Officer | David Fidanza Chief Information Officer |
Business Overview |
iCoreConnect Inc. is a cloud-based software and technology company. The Company is focused on increasing workflow productivity and practice profitability through its enterprise and healthcare workflow platform of applications and services. The Company is primarily engaged in providing solutions to solve the healthcare business problems. iCoreConnect touts a platform of over 16 software-as-a-service (SaaS) enterprise solutions and more than 100 agreements with state or regional healthcare associations across the United States. It offers solutions for the dental, medical and business information technology (IT) sectors. The Company offers cloud-based SaaS offering under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreVerify+, iCoreHuddle, iCoreHuddle+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, iCoreClaims, iCoreHIPAA, iCoreAcademy and iCoreIT. iCoreRx is an e-prescribing solution to improve efficiency, resource utilization, and patient safety. |
Financial Overview |
For the fiscal year ended 31 December 2023, iCoreConnect Inc revenues increased 2% to $8.2M. Net loss applicable to common stockholders increased from $7.9M to $15.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Software segment loss increase from $4.8M to $10.3M. |
Employees: | 67 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $17.76M as of Dec 31, 2023 |
Annual revenue (TTM): | $8.15M as of Dec 31, 2023 |
EBITDA (TTM): | -$9.00M as of Dec 31, 2023 |
Net annual income (TTM): | -$15.92M as of Dec 31, 2023 |
Free cash flow (TTM): | -$8.98M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $5.47M as of Dec 31, 2023 |
Shares outstanding: | 10,150,753 as of Apr 18, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |